Son güncelleme :
03/05/2024
Kanser ilaç   Durvalumab  
Enjeksiyon
Çözeltilerin stabilitesi Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Uygulama yöntemi Kaynaklar Pdf

Ticari isim   Ticari isim     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Imfinzi Almanya, Amerika Birleşik Devletleri, Büyük Britanya, Fransa, İsviçre, Kanada
Kaynaklar   Enjeksiyon    Kaynaklar : Durvalumab  
Tip Yayın
4608 Laboratuar Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021)
Astra Zeneca 2021
4767 Dergi Almasi K, Thiesen J, Krämer I.
Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening.
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1
4772 Dergi Porlier A, Gagnon P-Y, Chénard V, Michael N-J, Simard C, Drolet B.
Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage?
J Pharm Sci 2023 ; 112, 9: 2412-2418.

  Mentions Légales